NCT03525119 Immunogenicity and Safety of Tetravalent Dengue Vaccine (TDV) Co-administered With an Hepatitis A Virus Vaccine Status COMPLETED Phase PHASE3
NCT03522506 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults Status COMPLETED Phase PHASE1
NCT03506386 Multiple Myeloma (MM) Profile in Brazil: A Retrospective Observational Analysis Status COMPLETED Phase N/A
NCT03501277 A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants Status COMPLETED Phase PHASE1
NCT03498625 Crohn's Disease Endoscopic REmission Definition in an Objective Way Status COMPLETED Phase NA
NCT03497429 A Study of Niraparib as Single Agent in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1
NCT03488030 A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) Status COMPLETED Phase N/A
NCT03487900 Is the Endoscopic Remission Evaluation, Using the CREDO 1 Index / Score in CD Patients in Clinical Remission at Baseline, Predictive of Sustained Clinical Remission Using a 2-year Follow up Status UNKNOWN Phase NA
NCT03486990 Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease Status COMPLETED Phase PHASE1
NCT03469349 Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIB Status COMPLETED Phase PHASE3
NCT03459859 Pevonedistat and Low Dose Cytarabine in Adult Patients With AML and MDS Status COMPLETED Phase PHASE1
NCT03456960 A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet Status COMPLETED Phase PHASE1
NCT03439293 A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM) Status COMPLETED Phase PHASE2
NCT03437564 A Bioequivalence Study of the Lu AA21004 20 mg and 2×10 mg Tablets Status COMPLETED Phase PHASE1
NCT03434977 A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation Status COMPLETED Phase PHASE1
NCT03433001 A Study in Relapsed and/or Refractory Multiple Myeloma Patients Treated With Ixazomib Plus Lenalidomide and Dexamethasone Status COMPLETED Phase N/A
NCT03423173 Lot-to-lot Consistency of 3 Lots of Tetravalent Dengue Vaccine (TDV) in Non-endemic Country(Ies) for Dengue Status COMPLETED Phase PHASE3
NCT03420742 A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors Status COMPLETED Phase PHASE1
NCT03416374 A Study to Evaluate the Efficacy and Safety of Ixazomib in Combination With Lenalidomide and Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma Initially Treated With an Injection of Proteasome Inhibitor-Based Therapy Status COMPLETED Phase PHASE4